1. An Estimate of the Cost of Hepatitis C Treatment for the Brazilian Health System 
Carine Raquel Blatt, PhD, Noemia Liege Maria da Cunha Bernardo, MSc, Junior Andre Rosa, MSc, Fabiola Bagatini, MSc, Rodrigo Fernandes Alexandre, MSc, Giacomo Balbinotto Neto, PhD, Uwe Siebert, Mareni Rocha Farias, PhD 
Value in Health Regional Issues 
Volume 1, Issue 2, Pages (December 2012)
DOI: /j.vhri
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Percentage of total direct cost for treatment of hepatitis C with interferon alpha plus ribavirin and peginterferon alpha 2a 180 μg plus ribavirin. IFN, interferon alpha; PEG, peginterferon alpha; RBV, ribavirin.
Value in Health Regional Issues 2012 1, DOI: ( /j.vhri )
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions